On-Demand Webinar: How Payers Leverage Data Pipelines for 5-Star Results
Verinovum recently hosted the fourth installment of its New Truths series with partner Lyniate, a provider of platforms that [...]
Verinovum recently hosted the fourth installment of its New Truths series with partner Lyniate, a provider of platforms that [...]
Verinovum, Inc. recently utilized marketing partner Envision Health to execute a third-party market research study of Medicare Advantage (MA) programs in seven payer organizations of varying sizes and demographics. The goal of the study was to better understand the role and structure of MA programs within different kinds of payer organizations and how these payers and programs obtain and use clinical data for their most pressing needs.
A new partnership is bringing innovative solutions to payers across the nation. Verinovum, a leader in EHR clinical data curation [...]
As 2020 comes to a close, healthcare industry leaders are looking ahead to 2021 with excitement and anticipation. This year [...]
December 7 is the deadline for membership enrollment into Medicare Advantage (MA) plans. Star Ratings for MA plans were [...]
Verinovum, a health data curation and enrichment technology company, recently announced a partnership with CentraForce Health™, a data analytics company [...]
Managing disparate clinical data can be a challenge for even the most robust health system. Due to the complexity [...]
Healthcare data curation and enrichment company Verinovum today announced the launch of its new Data Curation as a Service (DCaaS) solution for [...]
Take a deep-dive into the risks and downstream impacts payer executive teams face when dealing with missing or flawed [...]
Disease management (DM), which has been around since the 1970s and became more prevalent with the advent of managed care, was designed to improve patient quality of life. By helping to ensure continuity of care and equipping patients with education and resources to better self-manage their conditions, people with chronic disease were shown to have better outcomes than those who did not participate in disease management programs.